Phase I DART

Patricia LoRusso, DO, Leader

Joseph Paul Eder , MD

Michael Cecchini, MD

Angela Davies, MD
Navid Hafez, MD, MPH
Joseph Kim, MD

Staff:

Mandy DeMerchant
Michael Lachowicz

Objectives:

1. To develop new and improved cancer therapeutics.
2. To maintain a portfolio of novel cancer therapeutics to service our cancer patient community
3. To assist in the development, understanding, characterization, and approval of new drug therapies
4. Strategically cultivate and nurture sponsored research activities

Research Meetings: Thursdays at 2pm in WWW 208

Operations Meeting: Tuesdays at 12pm

Tumor Board Meetings: 2nd Monday of the month at 4:30pm in Tumor Board Conference Room